INJ Rocket Fuel: Injective’s 15% Surge Ignites as EVM Testnet Goes Live & DeFi Alliances Expand
Injective (INJ) just pulled a classic crypto move—soaring 15% on pure momentum while traditional markets yawn. The catalyst? A one-two punch of tech rollout and partnership plays that have traders stacking INJ like degenerate gamblers at a Vegas high-roller table.
EVM Compatibility Drops—Game On
The layer-1 chain flipped the switch on its Ethereum Virtual Machine testnet, finally letting devs port Solidity contracts without rewriting their life's work. About damn time—interoperability is the only buzzword that still moves needles in this market.
Backroom Deals Pay Off
Meanwhile, Injective's BD team has been shaking hands with shadowy super coders and institutional "partners" (read: hedge funds testing crypto waters). No names dropped—because in DeFi, NDAs are the new white papers.
Cynical take? This pump reeks of coordinated hype before some VC unlock. But try telling that to the leverage junkies riding INJ's liquid markets to Valhalla. Just remember: in crypto, every breakout is a breakdown waiting to happen.
1.
Executive Summary
Injective (INJ) has emerged as one of the week’s top-performing cryptocurrencies, rallying 15.26% after breaking out of a multi-month descending channel. Key drivers include the launch of its Ethereum Virtual Machine (EVM) testnet, a 1,500% spike in daily active addresses, and the formation of the Injective Council in collaboration with Google Cloud and Deutsche Telekom. These developments underscore Injective’s growing influence in decentralized finance (DeFi) and institutional adoption, signaling further bullish potential.
2. Recent Market DevelopmentsEVM Testnet Launch Fuels Activity Growth
Injective's EVM testnet launch on July 9 has set the stage for a transformational phase. The testnet enhances compatibility with Ethereum-based assets, making Injective a prime contender for real-world asset tokenization. This milestone coincided with a stunning 1,700% increase in daily active addresses since January, reaching over 82,000, the highest activity level since December 2023.
Strategic Partnerships with Google Cloud and Deutsche Telekom
On July 12, Injective announced the formation of the Injective Council, which includes industry leaders like Google Cloud and Deutsche Telekom. This council aims to accelerate institutional integration and innovation in DeFi, opening doors for global asset tokenization and broader adoption.
Technical Breakout and Bullish Momentum
Injective’s price broke out of a long-standing descending channel, surging 15% to trade above $12. This movement was supported by rising trading volumes and positive funding rates, reflecting strong trader confidence. Analysts are now eyeing resistance levels at $14.16 and $15.43 for further upside.
On-Chain Usage Spikes by 1,500%
Injective’s on-chain usage has surged dramatically, with daily active addresses increasing 1,500% since January 2025. This growth highlights the success of the Nivara Upgrade and testnet launch, which have driven user and developer engagement to new heights.
- Current Price: $12.33
- 24h Volume: $18,200,822
- Trend: Weak Bullish
- Short-term indicators such as the 7-day SMA ($11.57) and 20-day SMA ($11.15) suggest bullish momentum.
- RSI (14): 58.54 - Indicates moderate bullish momentum, with room for further gains.
- MACD: Positive histogram of 0.2390 confirms bullish momentum, supported by a MACD line above the signal line.
- The price is nearing the upper band ($12.49), signaling potential resistance but also indicating strong upward pressure.
- Resistance 1: $13.16
- Resistance 2: $15.48
- Support 1: $10.07
- Support 2: $8.95
Given the recent breakout and bullish indicators, traders should monitor the following:
- A confirmed close above $13.16 could signal further upside toward $15.48.
- A retest of the broken descending trendline around $12.00 could present an ideal entry point for long positions.
- Stop-loss orders should be placed NEAR $10.07 to manage downside risk.
For short-term traders, momentum indicators like RSI and MACD suggest potential for quick gains, but caution is advised near key resistance zones.
5. Price Predictions and OutlookIf bullish momentum sustains:
-$14.16 (Resistance 1)
-$15.48 (Resistance 2)
In the long term, Injective’s focus on real-world asset tokenization and institutional partnerships could drive its price back toward its 52-week high of $34.02. However, breaking the $15.48 resistance will be critical for sustained growth.
6. Risk AnalysisWhile Injective’s recent developments are promising, traders must consider the following risks:
-Broader crypto market sentiment remains uncertain, which could impact INJ’s momentum.
-Failure to break key resistance zones at $14.16 and $15.48 could lead to a pullback.
-Regulatory pressures and economic uncertainty may influence institutional adoption and overall market conditions.
Injective (INJ) is gaining significant traction, underpinned by its EVM testnet launch, soaring on-chain activity, and strategic partnerships with global giants like Google Cloud. Technically, the breakout above $12 signals bullish momentum, with analysts eyeing $14.16 and $15.48 as key resistance levels. While risks remain, Injective’s focus on DeFi innovation and institutional integration positions it as a strong contender for long-term growth. Traders should remain vigilant for pullbacks and capitalize on buying opportunities near key support levels.
Image source: Shutterstock- inj price analysis
- inj price prediction
